313 related articles for article (PubMed ID: 23348790)
21. Evaluation of 99mTc-labeled cyclic RGD dimers: impact of cyclic RGD peptides and 99mTc chelates on biological properties.
Zhou Y; Kim YS; Lu X; Liu S
Bioconjug Chem; 2012 Mar; 23(3):586-95. PubMed ID: 22369387
[TBL] [Abstract][Full Text] [Related]
22. Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers.
Shi J; Kim YS; Chakraborty S; Zhou Y; Wang F; Liu S
Amino Acids; 2011 Nov; 41(5):1059-70. PubMed ID: 20052508
[TBL] [Abstract][Full Text] [Related]
23. Comparison of biological properties of (111)In-labeled dimeric cyclic RGD peptides.
Zheng Y; Ji S; Tomaselli E; Yang Y; Liu S
Nucl Med Biol; 2015 Feb; 42(2):137-45. PubMed ID: 25459111
[TBL] [Abstract][Full Text] [Related]
24. 99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics.
Shi J; Wang L; Kim YS; Zhai S; Jia B; Wang F; Liu S
Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1874-84. PubMed ID: 19484236
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of K(HYNIC)(2) as a bifunctional chelator for (99m)Tc-labeling of small biomolecules.
Ji S; Zhou Y; Shao G; Liu S
Bioconjug Chem; 2013 Apr; 24(4):701-11. PubMed ID: 23521129
[TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
Zhang X; Chen X
Appl Radiat Isot; 2007 Jan; 65(1):70-8. PubMed ID: 17011200
[TBL] [Abstract][Full Text] [Related]
27. Imaging integrin α(v)β(3) positive glioma with a novel RGD dimer probe and the impact of antiangiogenic agent (Endostar) on its tumor uptake.
Wu H; Chen H; Sun Y; Wan Y; Wang F; Jia B; Su X
Cancer Lett; 2013 Jul; 335(1):75-80. PubMed ID: 23403076
[TBL] [Abstract][Full Text] [Related]
28. Imaging of bronchioloalveolar carcinoma in the mice with the αⅤβ3 integrin-targeted tracer (99m)Tc-RGD-4CK.
Liu B; Feng Y; Zhang JY; Li HM; Li XD; Jia HL; Li ZY; Feng J
Transl Res; 2013 Sep; 162(3):174-80. PubMed ID: 23867618
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.
Liu S; Hsieh WY; Jiang Y; Kim YS; Sreerama SG; Chen X; Jia B; Wang F
Bioconjug Chem; 2007; 18(2):438-46. PubMed ID: 17341108
[TBL] [Abstract][Full Text] [Related]
30. Improved in Vivo Targeting Capability and Pharmacokinetics of
Gao H; Luo C; Yang G; Du S; Li X; Zhao H; Shi J; Wang F
Bioconjug Chem; 2019 Jul; 30(7):2038-2048. PubMed ID: 31063685
[TBL] [Abstract][Full Text] [Related]
31. (99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging.
Ji S; Czerwinski A; Zhou Y; Shao G; Valenzuela F; Sowiński P; Chauhan S; Pennington M; Liu S
Mol Pharm; 2013 Sep; 10(9):3304-14. PubMed ID: 23875883
[TBL] [Abstract][Full Text] [Related]
32. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
[TBL] [Abstract][Full Text] [Related]
34. FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues.
Zheng Y; Ji S; Czerwinski A; Valenzuela F; Pennington M; Liu S
Bioconjug Chem; 2014 Nov; 25(11):1925-41. PubMed ID: 25312799
[TBL] [Abstract][Full Text] [Related]
35. 99mTc-labeled cyclic RGD peptides for noninvasive monitoring of tumor integrin αVβ3 expression.
Zhou Y; Kim YS; Chakraborty S; Shi J; Gao H; Liu S
Mol Imaging; 2011 Oct; 10(5):386-97. PubMed ID: 21521559
[TBL] [Abstract][Full Text] [Related]
36. Blood clearance kinetics, biodistribution, and radiation dosimetry of a kit-formulated integrin αvβ3-selective radiotracer 99mTc-3PRGD 2 in non-human primates.
Jia B; Liu Z; Zhu Z; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
Mol Imaging Biol; 2011 Aug; 13(4):730-6. PubMed ID: 20694579
[TBL] [Abstract][Full Text] [Related]
37. Preclinical SPECT Imaging of Choroidal Neovascularization in Mice Using Integrin-Binding [
Ahn SJ; Lee HY; Hong HK; Jung JH; Park JH; Park KH; Kim SE; Woo SJ; Lee BC
Mol Imaging Biol; 2019 Aug; 21(4):644-653. PubMed ID: 30460625
[TBL] [Abstract][Full Text] [Related]
38. Coordination-Mediated Synthesis of Purification-Free Bivalent
Taira Y; Uehara T; Tsuchiya M; Takemori H; Mizuno Y; Takahashi S; Suzuki H; Hanaoka H; Akizawa H; Arano Y
Bioconjug Chem; 2018 Feb; 29(2):459-466. PubMed ID: 29320158
[TBL] [Abstract][Full Text] [Related]
39. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
[TBL] [Abstract][Full Text] [Related]
40. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]